Laser treatment for severe ROP may lead to severe myopia
In the treatment of patients with severe retinopathy of prematurity (ROP), laser appears to increase the trend to severe myopia, according to a study. Meanwhile, intravitreal bevacizumab does not affect myopic progression and reduces the need to consequently undergo laser treatment.